FindTrial
Sign In

Dual-timepoint 18F-FDG PET imaging for preoperative detection of axillary lymph node metastasis and postoperative IIIA (N2) staging in breast cancer: a comparative study

Dual-timepoint 18F-FDG PET imaging for preoperative detection of axillary lymph node metastasis and postoperative IIIA (N2) staging in breast cancer: a comparative study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039447
Enrollment
Unknown
Registered
2020-10-28
Start date
2020-11-09
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Gold Standard:Pathological results
Index test:Dual-timepoint&#32
18F-FDG&#32
PET&#32
imaging

Sponsors

The First People's Hospital of Yancheng
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All patients were unilateral lesions; 1-2 weeks before surgery underwent PET/CT dual-phase imaging.

Exclusion criteria

Exclusion criteria: Multiple lesions; Distant metastasis; Combined with other tumors; Tumor related treatment; Pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
the maximum standardized uptake value (SUVmax);SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactJiangong Zhang

The First People's Hospital of Yancheng

jiangongzh@126.com+86 15895181035

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026